gallocyanine has been researched along with Acute Confusional Senile Dementia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avramidis, N; Efthimiopoulos, S; Katsamakas, S; Mpousis, S; Sarli, V; Thysiadis, S | 2 |
2 other study(ies) available for gallocyanine and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Design and synthesis of gallocyanine inhibitors of DKK1/LRP6 interactions for treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Binding Sites; Cell Line, Tumor; Drug Design; Humans; Hydrogen Bonding; Intercellular Signaling Peptides and Proteins; Low Density Lipoprotein Receptor-Related Protein-6; Molecular Docking Simulation; Oxazines; Phosphorylation; Protein Interaction Domains and Motifs; Structure-Activity Relationship; tau Proteins; Wnt Signaling Pathway | 2018 |
Synthesis and evaluation of gallocyanine dyes as potential agents for the treatment of Alzheimer's disease and related neurodegenerative tauopathies.
Topics: Alzheimer Disease; Coloring Agents; Dose-Response Relationship, Drug; Humans; Intercellular Signaling Peptides and Proteins; Low Density Lipoprotein Receptor-Related Protein-1; Models, Molecular; Molecular Structure; Oxazines; Phosphorylation; Protein Binding; Structure-Activity Relationship; tau Proteins; Tauopathies | 2016 |